Crossmark

Dapagliflozin Improves Cardiac Function, Remodeling, Myocardial Apoptosis, and Inflammatory Cytokines in Mice with Myocardial Infarction

Published Online: 2021-12-02

Published Print: 2022-08

Authors

Wang, Kai

Li, Zhongming

Sun, Yan

Liu, Xianling

Ma, Wenjie

Ding, Yinzhang

Hong, Jian

Qian, Lijun

Xu, Di https://orcid.org/0000-0002-2176-8460
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (NO.81871359, NO. 82071944)
License Information

Text and Data Mining valid from 2021-12-02

Version of Record valid from 2021-12-02
More Information

Article History

Received: 15 August 2021

Accepted: 22 November 2021

First Online: 2 December 2021

Declarations

:

: All animal experiments were performed following the NIH guidelines. The Ethics Committee of Nanjing Medical University approved this study. No human studies were carried out by the authors for this article.

: The authors declare no competing interests.

Document is current